A Biomarker of Myocardial Fibrosis Predicts Long-Term Response to Cardiac Resynchronization Therapy

Journal of the American College of Cardiology

Volumn 47, Issue 11, 2006, Pages 2335-2337

  García Bolao, Ignacio ^a   Macías, Alfonso ^a   López, Begoña ^a   González, Arantxa ^a   Gavira, Juan J ^a   Azcárate, Pedro ^a   Alegría, Eduardo ^a   Díez, Javier ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HUMAN; LETTER; LONG TERM CARE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CARDIAC PACING, ARTIFICIAL; FIBROSIS; HUMANS; MYOCARDIUM; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 33646933811     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.012     Document Type: Letter

References (3)

1. López B., González A., Querejeta R., and Díez J. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease. J Hypertens 23 (2005) 1445-1451
2. López B., Querejeta R., González A., Sánchez E., Larman M., and Díez J. Effect of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43 (2004) 2028-2035
3. Querejeta R., López B., González A., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin. Relation to myocardial fibrosis. Circulation 110 (2004) 1263-1268